Status:
COMPLETED
Capsule Endoscopy in Cystic Fibrosis
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
10+ years
Brief Summary
Cystic Fibrosis patients continue to have bowel problems even after adequate pancreatic enzyme supplementation. There may be pathology of the lining of the bowel. Capsule endoscopy will be used to pho...
Detailed Description
The capsule endoscope system (Given Imaging, Ltd.) consists of 3 elements: a disposable capsule (PillCamTM SB) that acquires video images during natural propulsion through the digestive system. The v...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Inclusion criteria would include those subjects with known CF who are able to give informed consent to undergo capsule endoscopy and whose guardians provide consent as well, if applicable. -
- Exclusion Criteria
- Subjects would be excluded if they were felt to be poor surgical candidates as patients may need to undergo surgery in the rare event of retention of the capsule. Patients genotype and lung function will be noted; patients will be excluded if FEV1 \< 40%.
- \-
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00333957
Start Date
July 1 2006
End Date
August 1 2008
Last Update
May 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91240